Microalbuminuria in inflammatory bowel diseases using immunoturbidimetry and high-performance liquid chromatography

Acta Gastro-Enterologica Belgica

Volumn 72, Issue 4, 2009, Pages 394-401

  Szigeti, N ^a   Marko L ^a   Molnar G A ^a   Fabian Gy ^a   Cseh, J ^a   Mohas M ^a   Figler, M ^a   Kiraly A ^b   Koszegi T ^b   Wittmann, I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AZATHIOPRINE; BUDESONIDE; CREATININE; MESALAZINE; METHYLPREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ALBUMINURIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOTURBIDIMETRY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; TURBIDIMETRY; ULCERATIVE COLITIS; URINARY EXCRETION;

ADULT; ALBUMINURIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEPHELOMETRY AND TURBIDIMETRY; ROC CURVE;

EID: 76049114216     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. FIOCCHI C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology, 1998, 115 : 182-205.
2. MAHMUD N., STINSON J., O'CONNELL M.A., MANTLE T.J., KEELING P.W., FEELY J., WEIR D.G., KELLEHER D. Microalbuminuria in inflammatory bowel disease. Gut, 1994, 35 : 1599-1604.
3. MAHMUD N., MCDONALD G.S., KELLEHER D., WEIR D.G. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut, 1996, 38 : 99-103.
4. BEST W.R. Predicting the Crohn's disease activity index from the Harvey-Bradshaw index, Inflamm. Bowel Dis., 2006, 12 : 304-310.
5. HARVEY R.F., BRADSHAW J.M. A simple index of Crohn's disease activity. Lancet, 1980, 1: 514.
6. KANE S.V., SANDBORN W.J., RUFO P.A., ZHOLUDEV A., BOONE J., LYERLY D., CAMILLERI M., HANAUER S.B. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am. J. Gastroenterol., 2003, 98 : 1309-1314.
7. DAI J., LIU W.Z., ZHAO Y.P., HU Y.B., GE Z.Z. Relationship between fecal lactoferrin and inflammatory bowel disease. Scand. J. Gastroenterol., 2007, 42: 1440-1444.
8. D'HAENS G., SANDBORN W.J., FEAGAN B.G., GEBOES K., HANAUER S.B., IRVINE E.J., LÉMANN M., MARTEAU P., RUTGEERTS P., SCHÖLMERICH J., SUTHERLAND L.R. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology, 2007, 132 : 763-786.
9. FILIK L., DAGLI U., ULKER A. C-reactive protein and monitoring the activity of Crohn's disease. Adv. Ther., 2006, 23 : 655-662.
10. CHAMOUARD P., RICHERT Z., MEYER N., RAHMI G., BAUMANN R. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease. Clin. Gastroenterol. Hepatol., 2006, 4 : 882-887.
11. RODGERS A.D., CUMMINS A.G. CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease. Dig. Dis. Sci., 2007, 52 : 2063-2068.
12. VERMEIRE S., VAN ASSCHE G., RUTGEERTS P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm. Bowel Dis., 2004, 10 :661-665.
13. KAROUI S., OUERDIANE S., SERGHINI M., JOMNI T., KALLEL L., FEKIH M., BOUBAKER J., FILALI A. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease. Dig. Liver Dis., 2007, 39: 1006-1010.
14. PRANTERA C., DAVOLI M., LORENZETTI R., PALLONE F., MARCHEGGIANO A., IANNONI C., MARIOTTI S. Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J. Clin. Gastroenterol., 1988,10 : 41-45.
15. FAGAN E.A., DYCK R.F., MATON P.N., HODGSON H.J., CHADWICK V.S., PETRIE A., PEPYS M.B. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur. J. Clin. Invest., 1982, 12 : 351-359.
16. SACHAR D.B., SMITH H., CHAN S., COHEN LB., LICHTIGER S., MESSER J. Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J. Clin. Gastroenterol., 1986, 8: 647-650.
17. SACHAR D.B., LUPPESCU N.E., BODIAN C., SHLIEN R.D., FABRY T.L., GUMASTE V.V. Erythrocyte sedimentation as a measure of Crohn's disease activity : opposite trends in ileitis versus colitis. J. Clin. Gastroenterol., 1990, 12 : 643-646.
18. DERICI U., TUNCER C., EBINÇ F.A., MUTLUAY R., YAKARYILMAZ F., KULAKSIZOGLU S., SOYLEMEZOGLU O., SINDEL S. Does the urinary excretion of alpha 1-microglobulin and albumin predict clinical disease activity in ulcerative colitis? Adv. Ther., 2008, 25 : 1342-1352.
19. SUTHERLAND A.D., GEARRY R.B., FRIZELLE F.A. Review of fecal biomarkers in inflammatory bowel disease. Dis. Colon Rectum, 2008, 8 : 1283-1291.
20. GISBERT J.P., BERMEJO F., PÉREZ-CALLE J.L., TAXONERA C., VERA I., MCNICHOLL A.G., ALGABA A., LÓPEZ P., LÓPEZ-PALAClOS N., CALVO M., GONZÁLEZ-LAMA Y., CARNEROS J.A., VELASCO M., MATÉ J. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm. Bowel Dis., 2009, 15 : 1485-91.
21. JEFFERY J., LEWIS S.J., AYLING R.M. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders. Inflamm. Bowel Dis., 2009, 15 : 1630-4.
22. LAMBERS HEERSPINK H.J., BRINKMAN J.W., BAKKER S.J., GANSEVOORT RT., DE ZEEUW D. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr. Opin. Nephrol. Hypertens, 2006, 15 : 631-636.
23. OSICKA T.M., COMPER W.D. Characterization of immunochemically nonreactive urinary albumin. Clin. Chem., 2004, 50 : 2286-2291.
24. COMPER W.D., OSICKA T.M., JERUMS G. High prevalence of immunounreactive intact albumin in urine of diabetic patients. Am. J. Kidney Dis., 2003, 41: 336-342.
25. POLKINGHORNE K.R., SU Q., CHADBAN S.J., SHAW J.E., ZIMMET P.Z., ATKINS R.C. Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study : immunonephelometry compared with high-performance liquid chromatography. Am. J. Kidney Dis., 2006, 47 : 604-613.
26. MC QUEEN M.J., GERSTElN H.C., POGUE J., MANN J.F., YUSUF S. Reevaluation by high-performance liquid chromatography : clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am. J. Kidney Dis., 2006, 48 : 889-896.
27. LAMBERS HEERSPINK H.J., BRANTSMA A.H., DE ZEEUW D., BAKKER S.J., DE JONG P.E., GANSEVOORT R.T. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am. J. Epidemiol., 2008, 168: 897-905.
28. HOOGWERF B.J., LAINE D.C., GREENE E. Urine C-peptide and creatinine (Jaffe method) excretion in healthy young adults on varied diets : sustained effects of varied carbohydrate, protein, and meat content. Am. J. Clin. Nutr., 1986, 43 : 350-360.
29. OWEN W.E., ROBERTS W.L. Performance characteristics of an HPLC assay for urinary albumin. Am. J. Clin. Pathol., 2005, 124 : 219-225.
30. SATSANGI J., SILVERBERG M.S., VERMEIRE S., COLOMBEL J.F. The Montreal classification of inflammatory bowel disease : controversies, consensus, and implications. Gut, 2006, 55 : 749-753.
31. HALFVARSON J., JESS T., BODIN L., JÄRNEROT G., MUNKHOLM P., BINDER V., TYSK C. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm. Bowel Dis., 2007, 13 : 1536-1544.
32. COSNES J. Crohn's disease phenotype, prognosis, and long-term complications : what to expect ? Acta Gastroenterol Belg., 2008, 71 : 303-307.
33. DOBRE D., NIMADE S., DE ZEEUW D. Albuminuria in heart failure : what do we really know ? Curr. Opin. Cardiol., 2009, 24 : 148-154.
34. DE ZEEUW D., PARVING H.H., HENNING R.H. Microalbuminuria as an early marker for cardiovascular disease. J. Am. Soc. Nephrol., 2006, 17 : 2100-2105.
35. PONTREMOLI R., LEONCINI G., RAVERA M., VIAZZI F., VETTORETTI S., RATTO E., PARODI D., TOMOLILLO C., DEFERRARI G. Microalbuminuria, cardiovascular, and renal risk in primary hypertension. J. Am. Soc. Nephrol. 2002, 13 : SI69-172.
36. COMPER W.D., OSICKA T.M., CLARK M., MACISAAC R.J., JERUMS G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int., 2004, 65 : 1850-1855.
37. MAHMUD N., O'TOOLE D., O'HARE N., FREYNE P.J., WEIR D.G., KELLEHER D. Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis. Aliment Pharmacol. Ther., 2002, 16 : 207-215.
38. POULOU A.C., GOUMAS K.E., DANDAKIS D.C., TYRMPAS I., PANAGIOTAKI M., GEORGOULI A., SOUTOS D.C., ARCHIMANDRITIS A. Microproteinuria in patients with inflammatory bowel disease : is it associated with the disease activity or the treatment with 5-aminosalicylic acid ? World J. Gastroenterol., 2006,12 : 739-746.